Evaluation of Serial Lung Ultrasound Data After Surfactant Treatments Applied With Different Methods in Preterm Babies
Recruiting
N/A
Interventional Study
Newborn Complication
Respiratory Distress Syndrome, Newborn
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 1 Day – 5 Days
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 68 (estimated)
- Sponsor
- Konya City Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to investigate the relationship between the method of surfactant administration and improvements in serial lung ultrasound findings in preterm infants requiring surfactant therapy.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Infants of families who agree to participate in the study
* Preterm infants born before 32 weeks of gestation requiring surfactant therapy due to an RDS diagnosis.
Exclusion Criteria:
* Infants whose families did not provide consent
* Infants with a syndromic appearance or c…
Contacts